Advertisement
Screener

CRONOS GROUP INC. (CRON) Income (Loss) from Continuing Operations, Per Basic Share

2.8 / 5 stars · 68/120 Roast Me

CRONOS GROUP INC. Income (Loss) from Continuing Operations, Per Basic Share

CRONOS GROUP INC. (CRON) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.02 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2026-02-26

  • CRONOS GROUP INC. income (loss) from continuing operations, per basic share for the quarter ending 2024-09-30 was $0.02.
  • CRONOS GROUP INC. income (loss) from continuing operations, per basic share for the quarter ending 2024-06-30 was -$0.02.
  • CRONOS GROUP INC. income (loss) from continuing operations, per basic share for the quarter ending 2024-03-31 was -$0.01.
  • CRONOS GROUP INC. income (loss) from continuing operations, per basic share for the quarter ending 2023-09-30 was $0.00.
  • CRONOS GROUP INC. income (loss) from continuing operations, per basic share for fiscal 2025 was -$0.02, a 118.18% decline from fiscal 2024.
  • CRONOS GROUP INC. income (loss) from continuing operations, per basic share for fiscal 2024 was $0.11.
  • CRONOS GROUP INC. income (loss) from continuing operations, per basic share for fiscal 2023 was -$0.18.
  • CRONOS GROUP INC. income (loss) from continuing operations, per basic share for fiscal 2022 was -$0.41.
Period endIncome (Loss) from Continuing Operations, Per Basic Share 3 monthIncome (Loss) from Continuing Operations, Per Basic Share 3 month as first filedIncome (Loss) from Continuing Operations, Per Basic Share 6 monthIncome (Loss) from Continuing Operations, Per Basic Share 6 month as first filedIncome (Loss) from Continuing Operations, Per Basic Share 9 monthIncome (Loss) from Continuing Operations, Per Basic Share 9 month as first filedIncome (Loss) from Continuing Operations, Per Basic Share 12 monthIncome (Loss) from Continuing Operations, Per Basic Share 12 month as first filed
2025-12-31-$0.02
10-K · filed 2026-02-26
2024-12-31$0.11
10-K · filed 2026-02-26
2024-09-30$0.02
10-Q · filed 2024-11-12
-$0.01
10-Q · filed 2024-11-12
2024-06-30-$0.02
10-Q · filed 2024-08-08
-$0.03
10-Q · filed 2024-08-08
2024-03-31-$0.01
10-Q · filed 2024-05-09
2023-12-31-$0.18
10-K · filed 2026-02-26
2023-09-30$0.00
10-Q · filed 2024-11-12
-$0.07
10-Q · filed 2024-11-12
2023-06-30-$0.01
10-Q · filed 2024-08-08
-$0.06
10-Q · filed 2024-08-08
2023-03-31-$0.05
10-Q · filed 2024-05-09
2022-12-31-$0.41
10-K · filed 2025-02-27
-$0.45
10-K · filed 2023-02-28
2022-09-30-$0.09
10-Q · filed 2023-11-08
-$0.10
10-Q · filed 2022-11-07
-$0.21
10-Q · filed 2023-11-08
-$0.24
10-Q · filed 2022-11-07
2022-06-30-$0.05
10-Q · filed 2023-08-08
-$0.12
10-Q · filed 2023-08-08
-$0.14
10-Q · filed 2022-08-09
2022-03-31-$0.09
10-Q · filed 2023-05-09
2021-12-31-$0.34
10-K · filed 2024-02-29
-$1.07
10-K · filed 2022-03-01
2021-09-30$0.21
10-Q · filed 2022-11-07
-$0.71
10-Q · filed 2022-11-07
2021-06-30-$0.48
10-Q · filed 2022-08-09
$0.15
10-Q · filed 2021-08-06
-$0.92
10-Q · filed 2022-08-09
-$0.28
10-Q · filed 2021-08-06
2021-03-31-$0.44
10-Q · filed 2022-05-10
2020-12-31-$0.21
10-K · filed 2023-02-28
2020-09-30$0.20
10-Q · filed 2022-02-18
$0.11
10-Q · filed 2022-02-18
2020-06-30-$0.31
10-Q/A · filed 2022-02-18
-$0.09
10-Q/A · filed 2022-02-18
2020-03-31$0.22
10-Q · filed 2021-05-07
2019-12-31$3.76
10-K · filed 2022-03-01
2019-09-30$1.78
10-Q · filed 2020-11-05
$3.71
10-Q · filed 2020-11-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87